Associated Papers
Determination of CD177 (human neutrophil antigen 2) polymorphisms using nanopore sequencing.
Kløve-Mogensen K et al.
Vox Sanguinis, 2025
An explainable model of host genetic interactions linked to COVID-19 severity.
Onoja A et al.
Communications Biology, 2022
36289370 (PubMed )
Supplement: 42003_2022_4073_MOESM4_ESM.xlsx › S1
Human neutrophil antigen 2 sequence-based typing: Joining the hunt for the CD177 answer.
Browne T et al.
Vox Sanguinis, 2022
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.
Fontana D et al.
Hemasphere, 2020
33196013 (PubMed )
Supplement: hs9-4-e497-s007.xlsx › Sheet1
The nonconservative CD177 single-nucleotide polymorphism c.1291G>A is a genetic determinant for human neutrophil antigen-2 atypical/low expression and deficiency.
Wu J et al.
Transfusion, 2019
Heterogeneity of Human Neutrophil CD177 Expression Results from CD177P1 Pseudogene Conversion.
Wu Z et al.
Plos Genetics, 2016
Genetic mechanism of human neutrophil antigen 2 deficiency and expression variations.
Li Y et al.
Plos Genetics, 2015
Select a paper to view details